Skip to main content
Clinical Trials/KCT0008120
KCT0008120
Not yet recruiting
未知

Effects of age on Optimal effect-site concentration of remimazolam for efficacy of general anesthetic duction in female patients

Ajou University Hospital0 sites90 target enrollmentTBD
ConditionsNot Applicable

Overview

Phase
未知
Intervention
Not specified
Conditions
Not Applicable
Sponsor
Ajou University Hospital
Enrollment
90
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional Study
Sex
Female

Investigators

Sponsor
Ajou University Hospital

Eligibility Criteria

Inclusion Criteria

  • Female patients (20\-39 years old group, 40\-59 years old group, 60\-75 years old group ) who correspond to ASA 1 and 2, weight \<100 kg, and are scheduled to general anesthesia.

Exclusion Criteria

  • Patients with BMI \> 30 kg/m2 or \< 20 kg/m2, patients with contraindications such as allergies to this study drug, patients with hearing impairment, etc., who are unable to respond to the researcher's verbal command, or patients with liver disease (bilirubin \=3\.0 mg/dl, or aspartate amino transferase/alanine aminotransferase \= 2\.5 x upper limits of normal), renal disease (creatine \= 2 mg/dl), chronic obstructive pulmonary disease, uncontrolled hypertension ( e.g. Patients with systolic BP \=160 mmHg), diabetes (HbA1c \= 9%), moderate to severe coronary artery disease, glaucoma, heart failure, or taking other medications that may affect the effectiveness of benzodiazepines despite taking blood pressure medications If present, a history of smoking (within the last 6 months). If the IV line is placed on the back of the hand.

Outcomes

Primary Outcomes

Not specified

Similar Trials